APA

Gaudig M., Ireland S., Musingarimi P., Jackson C., Tweats E., Eriksson J. A. & Landfeldt E. (20160610). What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Chicago

Gaudig M, Ireland S, Musingarimi P, Jackson C, Tweats E, Eriksson J A and Landfeldt E. 20160610. What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Harvard

Gaudig M., Ireland S., Musingarimi P., Jackson C., Tweats E., Eriksson J. A. and Landfeldt E. (20160610). What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

MLA

Gaudig M, Ireland S, Musingarimi P, Jackson C, Tweats E, Eriksson J A and Landfeldt E. What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20160610.